Fan, Y., Zhang, Q., Yan, M., Qu, X., Yin, Y., Sun, T., . . . Xu, B. Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: A phase Ib study. Nature Portfolio.
Chicago Style (17th ed.) CitationFan, Ying, et al. Intravenous Liposomal Irinotecan in Metastatic Triple-negative Breast Cancer After ≥ 2 Prior Lines of Chemotherapy: A Phase Ib Study. Nature Portfolio.
MLA (9th ed.) CitationFan, Ying, et al. Intravenous Liposomal Irinotecan in Metastatic Triple-negative Breast Cancer After ≥ 2 Prior Lines of Chemotherapy: A Phase Ib Study. Nature Portfolio.
Warning: These citations may not always be 100% accurate.